Literature DB >> 186777

Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein.

M E Gnegy, P Uzunov.   

Abstract

Membranes of rat caudate nucleus contain a dopamine-dependent adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] and a Ca++ binding protein that activates phosphodiesterase (3':5'-cyclic-AMP 5'-nucleotidohydrolase, EC 3.1.4.17). This activator can be released from the membranes by a phosphorylation with a 3':5' cAMP-dependent protein kinase (ATP-protein phosphotransferase, EC 2.7.1.37). Under the conditions of membrane phosphorylation and activator release, dopamine fails to activate striatal adenylate cyclase. The basal activity of this enzyme is not decreased by the release of the protein activator but the activation by NaF is reduced. Adenylate cyclase is not phosphorylated when the dopamine activation is blocked after the release of the activator, but other membrane proteins are phosphorylated. It is postulated that the endogenous protein stored in striatal membranes can regulate the intracellular concentration of cAMP by an activation of adenylate cyclase while stored in striatal membrane, and by an activation of phosphodiesterase when released into the cytosol after membrane phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186777      PMCID: PMC431253          DOI: 10.1073/pnas.73.11.3887

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  A neurobiological role for a protein activator of cyclic nucleotide phosphodiesterase.

Authors:  P Uzunov; M Gnegy; R Lehne; A Revuelta; E Costa
Journal:  Adv Biochem Psychopharmacol       Date:  1976

2.  Adenyl cyclase. IV. The effects of neurohormones on the formation of adenosine 3',5'-phosphate by preparations from brain and other tissues.

Authors:  L M KLAINER; Y M CHI; S L FREIDBERG; T W RALL; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Protein activator of cyclic 3':5'-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase.

Authors:  W Y Cheung; L S Bradham; T J Lynch; Y M Lin; E A Tallant
Journal:  Biochem Biophys Res Commun       Date:  1975-10-06       Impact factor: 3.575

4.  Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase.

Authors:  C O Brostrom; Y C Huang; B M Breckenridge; D J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  The hepatic adenylate cyclase system. II. Substrate binding and utilization and the effects of magnesium ion and pH.

Authors:  M C Lin; Y Salomon; M Rendell; M Rodbell
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

7.  A kinetic analysis of the cyclic nucleotide phosphodiesterase regulation by the endogenous protein activator. A study of rat brain and frog sympathetic chain.

Authors:  P Uzunov; R Lehne; A V Revuelta; M E Gnegy; E Costa
Journal:  Biochim Biophys Acta       Date:  1976-02-13

8.  Regulation of transsynaptically elicited increase of 3':5'-cyclic AMP by endogenous phosphodiesterase activator.

Authors:  M E Gnegy; E Costa; P Uzunov
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  The hepatic adenylate cyclase system. III. A mathematical model for the steady state kinetics of catalysis and nucleotide regulation.

Authors:  M Rendell; Y Salomon; M C Lin; M Rodbell; M Berman
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

10.  Activation of adenylate cyclase by phosphoramidate and phosphonate analogs of GTP: possible role of covalent enzyme-substrate intermediates in the mechanism of hormonal activation.

Authors:  P Cuatrecasas; S Jacobs; V Bennett
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

View more
  8 in total

1.  Evidence for internalization of the recognition site of beta-adrenergic receptors during receptor subsensitivity induced by (-)-isoproterenol.

Authors:  D M Chuang; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

2.  Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.

Authors:  M E Gnegy; A Lucchelli; E Costa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-12       Impact factor: 3.000

3.  Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.

Authors:  G Biggio; M G Corda; M Casu; G L Gessa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

4.  beta-Adrenergic receptor regulation by agonists and membrane depolarization in rat brain slices.

Authors:  H R Wagner; J N Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

5.  Calmodulin in brain of schizophrenics.

Authors:  F Vargas; A Guidotti
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

6.  Distinct interactions between Ca2+/calmodulin and neurotransmitter stimulation of adenylate cyclase in striatum and hippocampus.

Authors:  M K Ahlijanian; D M Cooper
Journal:  Cell Mol Neurobiol       Date:  1988-12       Impact factor: 5.046

7.  Serotonin alters the subcellular distribution of a Ca2+/calmodulin-binding protein in neurons of Aplysia.

Authors:  T Saitoh; J H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Regulation of cyclic AMP metabolism in the rat erythrocyte during chronic beta-adrenergic stimulation. Evidence for calmodulin-mediated alteration of membrane-bound phosphodiesterase activity.

Authors:  C A Clayberger; D B Goodman; H Rasmussen
Journal:  J Membr Biol       Date:  1981-02-28       Impact factor: 1.843

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.